P125 Neoadjuvant pembrolizumab + chemotherapy vs placebo + chemotherapy followed by adjuvant pembrolizumab vs placebo for early TNBC: surgical outcomes from the phase 3 KEYNOTE-522 study

• S. Kümmel,
• P. Schmid,
• N. Harbeck,
• M. Takahashi,
• M. Untch,
• J.-F. Boileau,
• J. Cortes,
• H. McArthur,
• R. Dent,
• J. O’Shaughnessy,
• L. Pusztai,
• T. Foukakis,
• Y.H. Park,
• R. Hui,
• F. Cardoso,
• C. Denkert,
• Y. Zhu,
• W. Pan,
• V. Karantza,
• P. Fasching

Affiliations

S. Kümmel

P. Schmid

N. Harbeck

M. Takahashi

M. Untch

J.-F. Boileau

J. Cortes

H. McArthur

R. Dent

J. O’Shaughnessy

L. Pusztai

T. Foukakis

Y.H. Park

R. Hui

F. Cardoso

C. Denkert

Y. Zhu

W. Pan

V. Karantza

P. Fasching